Found 78 clinical trials
A randomized, double-blind study to test an oral medicine, Belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease.
>This study will help to find out if adding the investigational medication to your usual treatment (corticosteroid) is better, the same, or worse. The investigational medication (Belumosudil) is an
- 0 views
- 03 Dec, 2024
- 58 locations
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids
This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo controlled, 3-arm study for treatment of participants diagnosed with moderate-to-severe atopic dermatitis (AD) with a history of inadequate response of topical treatment, on background topical corticosteroid (TCS) and/or topical calcineurin inhibitor (TCI). The purpose of this study is …
- 0 views
- 03 Dec, 2024
- 87 locations
EFC16521 - WM Website Build
participate in clinical trials, especially those that have been historically under-represented. Complete a brief questionnaire to help determine if you may qualify to be referred to a site recruiting in
- 0 views
- 13 May, 2025
- 1 location
A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR
The main purpose is to evaluate the accuracy of myocardial imaging obtained through integrated 18F-FDG PET&x2F;MR in detecting viable myocardium. The secondary objective is to evaluate whether myocardial imaging obtained through integrated 18F-FDG PET&x2F;MR can replace 18F-FDG PET combined with 99mTc MIBI SPECT/;CT gated myocardial perfusion imaging.
- 0 views
- 03 Dec, 2024
- 2 locations
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
Add NCT# to populate
- 0 views
- 12 May, 2025
- 2 locations
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard
- 0 views
- 13 Feb, 2025
- 11 locations
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
The main objective of the study is to assess efficacy and safety of dupilumab given up to 24 weeks in adults with CPUO. This is a master protocol which includes 2 parallel-treatment, double-blind, 2- arm Phase 3 staggered studies of similar design (Study A and Study B) in male and …
- 0 views
- 30 May, 2024
- 41 locations